Allied Market Research published a report, titled, “Pain Patch Market by Therapeutic Class (Non-opioids and Opioids), Type (Prescription Medicines, and OTC Medicines), and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2022-2031″. According to the report, the global pain patch industry generated USD 4.8 billion in 2021 and is anticipated to generate USD 7.3 billion by 2031, witnessing a CAGR of 4.3% from 2022 to 2031.
๐๐ซ๐ข๐ฆ๐ ๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ง๐ญ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก
Rise in the prevalence of chronic pain such as back pain, arthritis and other chronic pain causing diseases, technological advancement in pain patches and rising adoption of pain patch for pain management, drive the growth of the global pain patch market. However, stringent regulatory guidelines for product approval and the availability of alternate treatments are hampering the pain patch market growth. On the contrary, the growth opportunities in emerging markets are expected to offer remunerative opportunities for the expansion of the pain patch market during the forecast period.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/A12676
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐ข๐ง ๐๐๐ญ๐๐ก ๐๐๐ซ๐ค๐๐ญ
- Viatris Inc.
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Hisamitsu Pharmaceutical Co. Inc.
- Endo International PLC.
- Nexgel Advanced Hydrogel Solutions
- Purdue Pharma L.P.
- Sorrento Therapeutics Inc.
- Amneal Pharmaceuticals LLC
- Grunenthal
๐๐๐ข๐ง ๐๐๐ญ๐๐ก ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
Based on product type, the non-opioids segment held the largest share in 2021, accounting for more than half of the global pain patch revenue, and is estimated to maintain its leadership status throughout the forecast period. Moreover, the same segment is projected to manifest the highest CAGR of 4.7% during the forecast period.
Based on type, the prescription medicines segment accounted for the largest share in 2021, accounting for more than 90% of the global pain patch revenue, owing to advantages as they provide correct number of drugs in the treatment of pain without causing much side effects, and commonly the opioids patches and NSAIDS are prescribed which are proven to be effective in chronic pain management.โฏ However, the OTC Medicines segment is projected to manifest the highest CAGR of 5.4% from 2022 to 2031, owing to rise in demand of personalization of pain management and availability of some pain patches without a prescription.
Based on distribution channel, the drug stores and retail pharmacies segment accounted for the largest share in 2021, accounting for more than half of the global pain patch revenue, owing to increase in preference of the people toward retail pharmacies, as retail pharmacies guide regarding medications and usage during treatment period. However, the online Providers segment is projected to manifest the highest CAGR of 7.7% from 2022 to 2031, owing to rise in popularity of online pharmacy and number of users preferring online providers.
Based on region, North America held the highest market share in terms of revenue in 2021, accounting for around two- fifth of the global pain patch revenue, owing to owing to rise in prevalence of chronic pain cases, presence of key players offering pain patches, ease of availability, higher awareness regarding pain patch, and developed healthcare infrastructure drive the growth of the pain patch market. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.3% from 2022 to 2031, and is likely to dominate the market during the forecast period, owing increase in investments for development of novel drug delivery system, surge in geriatric population and rise in awareness of advanced method for pain management thereby driving the growth of the market during the forecast period.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/request-sample/A12676
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
๐๐๐ ๐ข๐จ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:-
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐ฌ:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
